7 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Pubertycentral precocious puberty, endocrine system disorder, gonadal disorder, precocious pubertyRecruitingPhase 42026-07-29NCT07710430
Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)Acute Ischemic Stroke, Digestive System Diseases, Gastrointestinal Hemorrhage, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, digestive system disorder, ischemic stroke, nervous system disorder, stroke disorder, transient ischemic attack, vascular disorderRecruitingPhase 32026-07-08NCT07687706
Efficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious PubertyCPPActive, not recruitingPhase 42026-07-08NCT06926933
Evaluation of Effectiveness and Safety of Ultimaster™ Tansei™ Stent and/or Ultimaster Nagomi™ Stent in Routine Clinical PracticeArterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorderRecruitingNot stated2026-06-26NCT04443530
IRIS-Onyx Cohort in the IRIS-DES RegistryArterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorderActive, not recruitingNot stated2026-06-24NCT02593994
Observational Study for Left Main Disease TreatmentArterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorderRecruitingNot stated2026-03-20NCT01341327
Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)Nutritional and Metabolic Diseases, glucose intolerance, glucose metabolism disease, hyperglycemia, metabolic diseaseEnrolling by invitationPhase 42026-01-07NCT05579626